Interdisziplinäres Experten‐Treffen „Quo vadis beim kutanen Plattenepithelkarzinom“
暂无分享，去创建一个
[1] T. Lotti,et al. Melanoma and COVID‐19: A narrative review focused on treatment , 2020, Dermatologic therapy.
[2] J. Wolchok,et al. Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers , 2020, Cancer discovery.
[3] I. Zalaudek,et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. , 2020, European journal of cancer.
[4] C. Garbe,et al. S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ , 2020, Forum.
[5] P. Petrow,et al. Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN. , 2019, Journal of Clinical Oncology.
[6] A. Hauschild,et al. PD‐1 Blockade with Cemiplimab in Advanced Cutaneous Squamous‐Cell Carcinoma , 2018, The New England journal of medicine.
[7] C. Blauer-Peterson,et al. What are the health care costs for chronic lymphocytic leukemia , 2017 .